New CEO certainly distancing himself from ipo failure at end of last year
"Walker told CFO launching the listing at the end of the year was not good timing particularly in a strong year for biotechnology listings, with many fund managers unwilling to take on more risk from the sector.
“Nothing has changed except the timing,” he said. “It is a major market for our lead product. The markets and the doctors are there. We will bide our time and not set ourselves up [again] for such a public fall.”
- Forums
- ASX - By Stock
- Ann: CEO Appointment
New CEO certainly distancing himself from ipo failure at end of...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable